{
    "clinical_study": {
        "@rank": "144659", 
        "arm_group": [
            {
                "arm_group_label": "PC ventilation", 
                "arm_group_type": "Active Comparator", 
                "description": "Intervention with pressure controlled ventilator"
            }, 
            {
                "arm_group_label": "PRVC ventilation", 
                "arm_group_type": "Active Comparator", 
                "description": "Intervention with Pressure Regulated Volume Controlled Ventilator"
            }
        ], 
        "brief_summary": {
            "textblock": "Intracranial pressure (ICP) in patients with traumatic brain injury (TBI) is influenced by\n      several factors of which one is arterial CO2 tension. Patient with TBI are often sedated and\n      mechanically ventilated in order to secure a stable PaCO2. This study compares two\n      ventilation modus; Pressure Controlled Ventilation (PC) and Pressure Regulated Volume\n      Controlled ventilation (PRVC) in order to observe which of the two ventilation strategies\n      results in a more stable ICP and arterial CO2 pressure (PaCO2)."
        }, 
        "brief_title": "Respiratory Treatment of Patients With Moderate and Severe Traumatic Brain Injury", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Traumatic Brain Injury", 
        "condition_browse": {
            "mesh_term": [
                "Brain Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Informed consent obtained from the patients next-of-kin.\n\n          -  moderate or severe TBI according to Head Injury Severity Scale (Glasgow Coma Scale\n             (GCS) score 3-13).\n\n          -  treated at the neurosurgical ICU or the main ICU at St Olav University Hospital.\n\n          -  intubated and receiving controlled mechanical ventilation.\n\n          -  continuous measurement of ICP with either an intraventricular or an intraparenchymal\n             pressure monitor device.\n\n          -  sedation to a level of sedation corresponding to MAAS (Motor Activity Assessment\n             Score) 0 or 1 with continuous intravenous infusions of midazolam/propofol and\n             morphine/fentanyl/remifentanil14.\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  ICP above 25 mmHg\n\n          -  ongoing cerebral anti edema therapy corresponding to Step III at St Olav University\n             Hospital therapy guideline\n\n          -  continuous external drainage of cerebrospinal fluid (CSF)\n\n          -  Clinical pulmonary condition prohibiting changes in respiratory therapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01955785", 
            "org_study_id": "2013/1346"
        }, 
        "intervention": [
            {
                "arm_group_label": "PC ventilation", 
                "intervention_name": "pressure controlled ventilator", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "PRVC ventilation", 
                "intervention_name": "Pressure Regulated Volume Controlled Ventilator", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Traumatic brain injury", 
            "Intracranial pressure", 
            "Ventilation", 
            "Respiratory therapy"
        ], 
        "lastchanged_date": "November 27, 2013", 
        "location": {
            "contact": {
                "email": "pal.klepstad@ntnu.no", 
                "last_name": "P\u00e5l Klepstad, MB PhD", 
                "phone": "+47 72575709"
            }, 
            "facility": {
                "address": {
                    "city": "Trondheim", 
                    "country": "Norway", 
                    "zip": "7006"
                }, 
                "name": "Dept Intensive Care Medicine, St Olavs University Hospital"
            }, 
            "investigator": {
                "last_name": "Kari Shirmer-Mikalsen, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Norway"
        }, 
        "number_of_arms": "2", 
        "official_title": "Respiratory Treatment of Patients With Moderate and Severe Traumatic Brain Injury: A Randomised Comparison of Pressure Controlled Ventilation and Pressure Regulated Volume Controlled Ventilation", 
        "overall_official": {
            "affiliation": "NTNU", 
            "last_name": "P\u00e5l Klepstad, MD Ph D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Norway:National Committee for Medical and Health Research Ethics", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Each study period is two hours. All patients receive several study periods (max number 6) in a N=1 design", 
            "measure": "ICP", 
            "safety_issue": "No", 
            "time_frame": "Two hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01955785"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Each subject is studied in several study periods each of two hours duration (max number 6 periods). N=1 design", 
            "measure": "PaCO2", 
            "safety_issue": "No", 
            "time_frame": "Two hours"
        }, 
        "source": "Norwegian University of Science and Technology", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Norwegian University of Science and Technology", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}